HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune test could fine-tune virus prevention in transplant patients
Disease control OngoingThis study tests whether a blood test that measures CMV-specific immunity can help doctors decide how long to use the antiviral drug letermovir after a stem cell transplant. The goal is to prevent late-onset CMV infection, a common and serious complication. The trial involves 250…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New drug combo aims to make bone marrow transplants safer
Disease control OngoingThis phase 2 trial tests whether adding the drug tocilizumab to a standard transplant regimen can prevent graft failure and graft-versus-host disease in people with blood cancers receiving a special type of bone marrow transplant. The study involves 21 participants and aims to re…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Parent stem cells offer new hope for kids with blood cancer
Disease control OngoingThis study tests a new way to do stem cell transplants for 20 children with blood cancers or myelodysplasia who don't have a perfect donor match. Doctors remove certain immune cells from a parent's partially matched stem cells before transplant to help the new cells grow faster a…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:58 UTC
-
Donor immune cells get a boost in new cancer trial
Disease control TerminatedThis early-phase study tests whether giving healthy donor NK cells along with two medicines (vactosertib and IL-2) is safe and helps the cells stay active in people with advanced colorectal, stomach, esophageal, or blood cancers. The NK cells are meant to attack cancer, but the b…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Jun 01, 2026 17:53 UTC
-
Can a smartphone app ease the burden on bone marrow transplant caregivers?
Symptom relief OngoingThis study tests a mobile app called CARE designed to support caregivers of people receiving a bone marrow transplant. The goal is to see if using the app improves the caregiver's quality of life and reduces stress. About 120 adult caregivers will participate, and their well-bein…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 18, 2026 11:52 UTC
-
Lab-Grown 3D tumors could personalize blood cancer treatment
Knowledge-focused OngoingThis study creates 3D organoids from bone marrow samples of 70 people with blood cancers to test how well different chemotherapy combinations kill cancer cells. The goal is to see if these lab models can predict which treatment works best for each patient, especially when the can…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:54 UTC
-
CAR-T therapy safety check: researchers track Long-Term effects in 178 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 178 people who previously received AvenCell's CAR-T cell therapy for blood cancers or prostate cancer. The goal is to monitor long-term safety, including delayed side effects like new cancers or autoimmune problems. Participants are not receiving new trea…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: AvenCell Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:53 UTC
-
Cancer tissue bank study aims to unlock new treatment targets
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects leftover tissue and blood samples from 1,200 adults with known or suspected cancer during their standard surgeries or biopsies. Researchers will compare cancerous and normal tissues to find differences that could lead to new treatments. No extra procedures are…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:52 UTC
-
Can tablets replace paper for senior cancer patients?
Knowledge-focused OngoingThis study looks at whether older adults with cancer can use computer surveys (like on a tablet or computer) to answer health questions. Researchers want to see if these digital tools are easy to use, reliable, and give the same results as paper surveys. About 100 people aged 65 …
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC
-
Blood cancer patients with drug allergies may get safer antibiotics thanks to new study
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how doctors and patients feel about a new approach to picking antibiotics for people with blood cancers who have a reported penicillin allergy. The goal is to understand what might make it easier or harder to use this approach in everyday hospital care. About …
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC
-
15-Year safety check for caribou cell therapy patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 150 people who previously received Caribou cell therapy for blood cancers like lymphoma or leukemia. Researchers will check for long-term side effects and overall survival for up to 15 years after treatment. No new treatment is given—this is just observat…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Caribou Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
New study tests positive psychology for stressed transplant caregivers
Knowledge-focused OngoingThis study tests a program called PATH-C that uses positive psychology exercises to improve well-being, quality of life, and physical activity in caregivers of stem cell transplant patients. About 80 adult caregivers will be randomly assigned to the program or usual support. The …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC